Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exxon Mobil | NYSE | Energy | Oil & Gas | $468.25B | 13.2x | -0.68 | $106.54 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22% Upside | Upgrade to Pro+ | |
VICI Properties | NYSE | Real Estate | Residential & Commercial REITs | $29.74B | 10.5x | 0.78 | $28.21 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.1% Upside | Upgrade to Pro+ | |
Fifth Third | NASDAQ | Financials | Banking Services | $27.57B | 13.6x | -0.92 | $41.12 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24% Upside | Upgrade to Pro+ | |
Dow | NYSE | Basic Materials | Chemicals | $27.05B | 25.7x | -1.42 | $38.50 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.4% Upside | Upgrade to Pro+ | |
Regions Financial | NYSE | Financials | Banking Services | $20.96B | 13.6x | -0.49 | $23.06 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.4% Upside | Upgrade to Pro+ | |
Xp | NASDAQ | Financials | Investment Banking & Investment Services | $5.99B | 8.5x | 0.44 | $11.16 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gerdau ADR | NYSE | Basic Materials | Metals & Mining | $5.50B | 7.8x | -0.17 | $2.72 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.9% Upside | Upgrade to Pro+ | |
Valley National | NASDAQ | Financials | Banking Services | $4.81B | 13.7x | -0.33 | $8.62 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.6% Upside | Upgrade to Pro+ | |
Alight | NYSE | Technology | Software & IT Services | $3.48B | -10.7x | 0.6 | $6.54 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Geron | NASDAQ | Healthcare | Biotechnology & Medical Research | $1.92B | -9.9x | -1.79 | $3.17 | -7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immunitybio Inc | NASDAQ | Healthcare | Biotechnology & Medical Research | $1.69B | -2.8x | -0.19 | $2.42 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Applied Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | $79.02M | -0.5x | 0.18 | $0.68 | -6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioLineRx | NASDAQ | Healthcare | Biotechnology & Medical Research | $16.55M | -0.8x | -0.01 | $0.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Crown Electrokinetics | NASDAQ | Basic Materials | Construction Materials | $6.61M | -0x | $0.10 | -16.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |